首页> 外文期刊>BMC Medical Genomics >A novel recessive PDZD7 bi-allelic mutation in an Iranian family with non-syndromic hearing loss
【24h】

A novel recessive PDZD7 bi-allelic mutation in an Iranian family with non-syndromic hearing loss

机译:一种新型隐性PDZD7在伊朗家庭中具有非综合征听力损失的基本突变

获取原文
           

摘要

Autosomal recessive non-syndromic hearing loss (ARNSHL) is genetically and phenotypically heterogeneous with over 110 genes causally implicated in syndromic and non-syndromic hearing loss. Here, we investigate the genetic etiology of deafness in two?GJB2 and GJB6 negative patients presenting with pre-lingual, progressive, severe hearing loss. Targeted exome sequencing (TES) using Next Generation Illumina Sequencing was used to analyze the exonic and some other important genomic regions of 154 genes in the proband. Subsequently, the mutation found was confirmed by Sanger sequencing in other affected sibling and healthy family members. The possible impact of the reported mutation on the corresponding protein was also evaluated by using bioinformatics tools. Moreover, the affected patients underwent audiological and ophthalmic evaluations. TES identified a novel homozygous missense mutation c.251TC (p.I84T) in exon 3 of PDZD7 gene. In addition, segregation and phenotype-genotype correlation analysis as well as in-silico evaluations confirmed the autosomal recessive inheritance pattern and disease-causing nature of mutation found. In overall, our finding could expand the pathogenic mutations spectrum and strengthens the clinical importance of the PDZD7 gene in ARNSHL patients. It can also aid to conduct genetic counseling, prenatal diagnosis and clinical management of these types of genetic disorders.
机译:常染色体隐性非综合征听力损失(ARNSHL)是遗传和表型异质,具有超过110个基因因思科和非综合征听力损失而导致。在这里,我们调查两种耳聋的遗传病程,GJB2和GJB6阴性患者呈现前术前,渐进性严重的听力损失。使用下一代Illumina测序的靶向外序列测序(TES)分析了证书中154个基因的外源和一些重要的基因组区域。随后,发现发现的突变被其他受影响的兄弟和健康的家庭成员中的Sanger测序证实。还通过使用生物信息学工具评估报告的突变对相应蛋白质的可能影响。此外,受影响的患者接受了视力学和眼科评估。 TES鉴定了PDZD7基因外显子3中的新型纯合物畸变突变C.251T& C(p.i84t)。此外,偏析和表型基因型相关分析以及硅基评价证实了发现突变的常染色体隐性遗传性模式和疾病性质。总体而言,我们的发现可以扩大致病性突变谱,并强化ARNSHL患者PDZD7基因的临床重要性。它还可以帮助进行这些类型的遗传疾病的遗传咨询,产前诊断和临床管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号